Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 5
2009 3
2012 6
2013 5
2014 8
2015 14
2016 13
2017 16
2018 16
2019 10
2020 10
2021 14
2022 13
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Structural basis of selective cannabinoid CB2 receptor activation.
Li X, Chang H, Bouma J, de Paus LV, Mukhopadhyay P, Paloczi J, Mustafa M, van der Horst C, Kumar SS, Wu L, Yu Y, van den Berg RJBHN, Janssen APA, Lichtman A, Liu ZJ, Pacher P, van der Stelt M, Heitman LH, Hua T. Li X, et al. Among authors: heitman lh. Nat Commun. 2023 Mar 15;14(1):1447. doi: 10.1038/s41467-023-37112-9. Nat Commun. 2023. PMID: 36922494 Free PMC article.
Targeting the CCL2-CCR2 axis for atheroprotection.
Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M. Georgakis MK, et al. Among authors: heitman lh. Eur Heart J. 2022 May 14;43(19):1799-1808. doi: 10.1093/eurheartj/ehac094. Eur Heart J. 2022. PMID: 35567558 Review.
Kinetic Profile of Neuropeptide-Receptor Interactions.
Nederpelt I, Bunnik J, IJzerman AP, Heitman LH. Nederpelt I, et al. Among authors: heitman lh. Trends Neurosci. 2016 Dec;39(12):830-839. doi: 10.1016/j.tins.2016.09.008. Epub 2016 Oct 25. Trends Neurosci. 2016. PMID: 27793433 Review.
Molecular probes for the human adenosine receptors.
Yang X, Heitman LH, IJzerman AP, van der Es D. Yang X, et al. Among authors: heitman lh. Purinergic Signal. 2021 Mar;17(1):85-108. doi: 10.1007/s11302-020-09753-8. Epub 2020 Dec 12. Purinergic Signal. 2021. PMID: 33313997 Free PMC article. Review.
Oncological drug discovery: AI meets structure-based computational research.
Gorostiola González M, Janssen APA, IJzerman AP, Heitman LH, van Westen GJP. Gorostiola González M, et al. Among authors: heitman lh. Drug Discov Today. 2022 Jun;27(6):1661-1670. doi: 10.1016/j.drudis.2022.03.005. Epub 2022 Mar 14. Drug Discov Today. 2022. PMID: 35301149 Free article. Review.
Anticancer opportunities at every stage of chemokine function.
Ortiz Zacarías NV, Bemelmans MP, Handel TM, de Visser KE, Heitman LH. Ortiz Zacarías NV, et al. Among authors: heitman lh. Trends Pharmacol Sci. 2021 Nov;42(11):912-928. doi: 10.1016/j.tips.2021.08.001. Epub 2021 Sep 11. Trends Pharmacol Sci. 2021. PMID: 34521537 Review.
Intracellular Receptor Modulation: Novel Approach to Target GPCRs.
Ortiz Zacarías NV, Lenselink EB, IJzerman AP, Handel TM, Heitman LH. Ortiz Zacarías NV, et al. Among authors: heitman lh. Trends Pharmacol Sci. 2018 Jun;39(6):547-559. doi: 10.1016/j.tips.2018.03.002. Epub 2018 Apr 10. Trends Pharmacol Sci. 2018. PMID: 29653834 Free PMC article. Review.
Bias in chemokine receptor signalling.
Zweemer AJ, Toraskar J, Heitman LH, IJzerman AP. Zweemer AJ, et al. Among authors: heitman lh. Trends Immunol. 2014 Jun;35(6):243-52. doi: 10.1016/j.it.2014.02.004. Epub 2014 Mar 26. Trends Immunol. 2014. PMID: 24679437 Review.
Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ, Superti-Furga G, IJzerman AP, Heitman LH. Sijben HJ, et al. Among authors: heitman lh. Trends Pharmacol Sci. 2022 May;43(5):358-361. doi: 10.1016/j.tips.2022.02.004. Epub 2022 Feb 26. Trends Pharmacol Sci. 2022. PMID: 35232590 Free article.
134 results